Real-time enrollment status for this chronic stable angina pectoris clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 10:29 PM UTC
| NCT Number | NCT03789552 |
| Recruiting Status | Recruiting |
| Condition | Chronic Stable Angina Pectoris |
| Phase | PHASE3 |
| Target Enrollment | 765 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Tasly Pharmaceuticals, Inc. |
| Last Updated on CT.gov | April 9, 2025 (Apr 9, 2025) |
As of September 3, 2026: Clinical trial NCT03789552 is currently recruiting participants. This phase3 study for chronic stable angina pectoris is actively seeking new participants at 1 location across the United States. The study is sponsored by Tasly Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03789552 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03789552 was last updated Apr 9, 2025 (April 9, 2025). HelloStudys verifies this status automatically.